Sign In
Buy CNS
$70.20
-1.00 (-1.40%)
At Close: Jun 03, 2026
Cohen & Steers Announces Preliminary Assets Under Management and Net Flows for January 2026
06:55am, Monday, 09'th Feb 2026
NEW YORK, Feb. 9, 2026 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under management of $93.1 billion as of January 31, 2026, an increase of $2.5 billion from as
Alps Advisors Inc. Boosts Stock Position in Cohen & Steers Inc $CNS
04:38am, Monday, 09'th Feb 2026
Alps Advisors Inc. increased its stake in Cohen and Steers Inc (NYSE: CNS) by 37.8% in the undefined quarter, according to the company in its most recent disclosure with the SEC. The institutional inv
PreveCeutical Announces Filing of Patent for Delivery of CNS-Active Agents
03:00am, Monday, 09'th Feb 2026
Vancouver, British Columbia--(Newsfile Corp. - February 9, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") is pleased to announce it has
FHI vs. CNS: Which Stock Is the Better Value Option?
12:41pm, Friday, 06'th Feb 2026
Investors looking for stocks in the Financial - Investment Management sector might want to consider either Federated Hermes (FHI) or Cohen & Steers Inc (CNS). But which of these two stocks presents in
Alger Weatherbie Specialized Growth Fund Q4 2025 Winners And Laggards
10:00am, Tuesday, 03'rd Feb 2026
Class A shares of the Alger Weatherbie Specialized Growth Fund outperformed the Russell 2500 Growth Index during the fourth quarter of 2025. Natera, Inc., ACADIA Pharmaceuticals Inc., and Glaukos Corp
SEQSTER Announces Expanded Partnership with Praxis Precision Medicines to Accelerate Clinical Trials in CNS Disorders
09:57am, Monday, 02'nd Feb 2026
SAN DIEGO & BOSTON--(BUSINESS WIRE)--SEQSTER, the leading healthcare technology company and the data connection, collection, and orchestration layer for patient health data, and Praxis Precision Medic
Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a)
05:52pm, Tuesday, 27'th Jan 2026
NEW YORK, Jan. 27, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE: FOF) (the "Fund") with information regarding the sources of
Cohen & Steers Infrastructure Fund, Inc. (UTF) Notification of Sources of Distribution Under Section 19(a)
05:48pm, Tuesday, 27'th Jan 2026
NEW YORK, Jan. 27, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Infrastructure Fund, Inc. (NYSE: UTF) (the "Fund") with information regarding the sources of the dist
Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)
05:48pm, Tuesday, 27'th Jan 2026
NEW YORK, Jan. 27, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the sou
Cohen & Steers Quality Income Realty Fund, Inc. (RQI) Notification of Sources of Distribution Under Section 19(a)
05:45pm, Tuesday, 27'th Jan 2026
NEW YORK, Jan. 27, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Quality Income Realty Fund, Inc. (NYSE: RQI) (the "Fund") with information regarding the sources of t
Cohen & Steers Total Return Realty Fund, Inc. (RFI) Notification of Sources of Distribution Under Section 19(a)
05:38pm, Tuesday, 27'th Jan 2026
NEW YORK, Jan. 27, 2026 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Total Return Realty Fund, Inc. (NYSE: RFI) (the "Fund") with information regarding the sources of the
'Stayin' Alive' In 2026 With The Cohen & Steers Closed-End Opportunity Fund
03:00pm, Tuesday, 27'th Jan 2026
"Stayin' Alive" worked for John Travolta in "Saturday Night Fever" and it's a worthy investment goal for me, given the economic, financial, and geopolitical risks we face in 2026. Finding a single inv
CNS Pharmaceuticals Issues Letter to Shareholders
09:00am, Tuesday, 27'th Jan 2026
Newly Appointed President & Chief Executive Officer, Rami Levin, Discusses Plans for a New Era at CNS Pharmaceuticals Strategic Focus, Pipeline Optimization and Formalizing Roadmap for Near and Long-T
Ovid Therapeutics: Bullish Post-PIPE With 2 Differentiated CNS Moonshots
11:01pm, Monday, 26'th Jan 2026
Ovid Therapeutics targets neuronal hyperexcitability with two small-molecule platforms. 1) OV329 (GABA-AT inhibition) and 2) KCC2 direct activators for neuropsychiatric disorders. OV329 Phase 2a in dr
Cohen & Steers: Cheap Enough To Buy As Income Comes Back Into Focus (Upgrade)
01:04am, Monday, 26'th Jan 2026
Cohen & Steers is upgraded to 'Buy' as the valuation now reflects improving fundamentals and a favorable 2026 outlook. Despite weak REIT demand, CNS maintains strong fund performance, with 95% of fund
